Naresh Aggarwal

2.7k total citations · 1 hit paper
27 papers, 860 citations indexed

About

Naresh Aggarwal is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Naresh Aggarwal has authored 27 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Naresh Aggarwal's work include Respiratory viral infections research (6 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (5 papers). Naresh Aggarwal is often cited by papers focused on Respiratory viral infections research (6 papers), Diabetes Management and Research (5 papers) and Diabetes Treatment and Management (5 papers). Naresh Aggarwal collaborates with scholars based in United States, Canada and Belgium. Naresh Aggarwal's co-authors include George Capuano, David Polidori, Yue Zhao, William Canovatchel, Keith Usiskin, Julio Rosenstock, Michael Zlowodzki, Joanne M. Langley, Olivier Godeaux and Shelly McNeil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and The Journal of Infectious Diseases.

In The Last Decade

Naresh Aggarwal

25 papers receiving 835 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes

2012 364 citations Naresh Aggarwal et al. profile →

Peers

Countries citing papers authored by Naresh Aggarwal

Since Specialization

Citations

This map shows the geographic impact of Naresh Aggarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naresh Aggarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naresh Aggarwal more than expected).

Fields of papers citing papers by Naresh Aggarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naresh Aggarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naresh Aggarwal. The network helps show where Naresh Aggarwal may publish in the future.

Co-authorship network of co-authors of Naresh Aggarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Naresh Aggarwal. A scholar is included among the top collaborators of Naresh Aggarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naresh Aggarwal. Naresh Aggarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection 2023 ·Clinical Microbiology and Infection ·Anna Nilsson, John Pullman, Piotr Napora, Kléber Giovanni Luz, Anil Kumar Gupta, (unknown), (unknown), Naresh Aggarwal, (unknown), Juliana Ianus, Leen Vijgen, Jane Scott, Rekha Sinha, Sarah Rusch, Dymphy Huntjens, (unknown), Marita Stevens	9
2	Replacement of a Björk-Shiley tilting disc mitral valve prosthesis 33 years after initial replacement 2022 ·Indian Journal of Thoracic and Cardiovascular Surgery ·Yugal Mishra, Naresh Aggarwal, (unknown), (unknown)	0
3	Pro: Propofol Is a Better Induction Agent than Etomidate 2021 ·SHILAP Revista de lepidopterología ·Naresh Aggarwal	0
4	Effect of teriparatide in fracture healing of intertrochanteric fracture: a prospective study 2018 ·International Journal of Research in Orthopaedics ·(unknown), Naresh Aggarwal, Ajay Sharma	1
5	A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su 2017 ·Vaccine ·Ana Strezova, Olivier Godeaux, Naresh Aggarwal, Geert Leroux‐Roels, Marta López‐Fauqued, Pierre Van Damme, Carline Vanden Abeele, (unknown), Thomas C. Heineman, Himal Lal	9
6	Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older 2017 ·The Journal of Infectious Diseases ·Tino F. Schwarz, Naresh Aggarwal, (unknown), Isabelle Schenkenberger, Carine Claeys, Martine Douha, Olivier Godeaux, (unknown), Thomas C. Heineman, Marta López‐Fauqued, Lidia Oostvogels, Peter van Steen, Himal Lal	59
7	A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant 2016 ·The Journal of Infectious Diseases ·Joanne M. Langley, Naresh Aggarwal, (unknown), Scott A. Halperin, Shelly McNeil, Laurence Fissette, Walthère Dewé, Maarten Leyssen, Jean‐François Toussaint, Ilse Dieussaert	53
8	Randomized, Phase III Clinical Trial to Assess the Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine Co-Administered With a Seasonal Quadrivalent-Inactivated Influenza Vaccine in Adults Aged 50 Years and Older 2016 ·Open Forum Infectious Diseases ·Tino F. Schwarz, Naresh Aggarwal, (unknown), Isabelle Schenkenberger, Carine Claeys, Olivier Godeaux, (unknown), Thomas C. Heineman, Lidia Oostvogels, Peter van Steen, Himal Lal	4
9	Two dose‐ranging studies with PF ‐04937319, a systemic partial activator of glucokinase, as add‐on therapy to metformin in adults with type 2 diabetes 2015 ·Diabetes Obesity and Metabolism ·Neeta B. Amin, Naresh Aggarwal, Dénes Páll, György Paragh, William S. Denney, Lê Văn Duyệt, Michael R. Riggs, Roberto A. Calle	36
10	Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial 2014 ·Journal of the Pediatric Infectious Diseases Society ·Joanne M. Langley, Long Wang, Naresh Aggarwal, (unknown), Vijayalakshmi Chandrasekaran, (unknown), Scott A. Halperin, Ping Li, Aixue Liu, Shelly McNeil, (unknown), Luis Rivera, Bruce L. Innis, Varsha Jain	26
11	Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children 2013 ·The Journal of Infectious Diseases ·Joanne M. Langley, (unknown), Archana Chatterjee, Scott A. Halperin, Shelly McNeil, Keith S. Reisinger, Naresh Aggarwal, Li‐Min Huang, Ching‐Tien Peng, José García-Sicilia, Ignacio Salamanca de la Cueva, Fernando Cabañas, (unknown), M Weber, (unknown), Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L. Innis, Varsha Jain	51
12	Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial 2013 ·Vaccine ·William H. Yang, Marc Dionne, (unknown), Naresh Aggarwal, Ping Li, Miguel G. Madariaga, Olivier Godeaux, David W. Vaughn	32
13	Randomized, Multicenter Trial of a Single Dose of AS03-adjuvanted or Unadjuvanted H1N1 2009 Pandemic Influenza Vaccine in Children 6 Months to <9 Years of Age 2012 ·The Pediatric Infectious Disease Journal ·Joanne M. Langley, (unknown), Naresh Aggarwal, David A. Connor, Marc Lebel, Anil K. Gupta, Hartley Garfield, Ping Li, (unknown), David W. Vaughn	13
14	Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls 2011 ·Journal of Adolescent Health ·Court Pedersen, Morten Breindahl, Naresh Aggarwal, Johan Berglund, (unknown), Sven‐Arne Silfverdal, (unknown), Michael O’Mahony, Marie‐Pierre David, Kurt Dobbelaere, Gary Dubin, Dominique Descamps	23
15	Management of A Case of Endobronchial Blood Clot in the Post Operative Period 2009 ·SHILAP Revista de lepidopterología ·Jyotirmoy Das, (unknown), (unknown), Naresh Aggarwal	1
16	Management of a case of endobronchial blood clot in the post operative period. 2009 ·PubMed ·(unknown), (unknown), (unknown), Naresh Aggarwal	1
17	Study of correlation between intracranial hemorrhages and skull fractures 2008 ·Journal of Forensic Medicine ·(unknown), Anil Kohli, Naresh Aggarwal	2
18	Familial prevalence among first-degree relatives of celiac disease in North India 2007 ·Digestive and Liver Disease ·R. Grover, (unknown), Naresh Aggarwal, Puja Sakhuja	17
19	External fixation of complex femoral shaft fractures 2006 ·International Orthopaedics ·Michael Zlowodzki, (unknown), Naresh Aggarwal	35
20	EXTERNAL FIXATION OF INTERTROCHANTERIC FRACTURES-AN ALTERNATIVE IN POOR RISK PATIENTS 1995 ·Journal of Orthopaedic Science ·Naresh Aggarwal, Govind Singh	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact